We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01612182
Recruitment Status : Completed
First Posted : June 5, 2012
Last Update Posted : June 5, 2012
Information provided by (Responsible Party):
Hoseok Koo, Inje University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : May 2012